Catalyst
Slingshot members are tracking this event:
BioMarin's (BMRN) Marketing Application for CLN2 Disease Treatment Ceriponase Alfa Approved by EMA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BMRN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Medicines Agency, Marketing Authorization Application, Approval, Cln2 Disease, Ceriponase Alfa
